Risk factors

Dow Inc.'s risk profile is dominated by chemical industry supply and demand volatility, raw material feedstock costs, and environmental liabilities. Additional major exposures include greenhouse gas regulations, litigation including Union Carbide asbestos claims, and plastic waste concerns.

International operations generate approximately 70% of 2024 net sales, creating heavy exposure to emerging markets like China and geopolitical conflicts. Restructuring and transformation efforts under UpLift carry operational and execution risks. Accurate cost and timing estimation is vital due to competitive bidding on contracts.

Water scarcity and climate change threaten essential agricultural raw materials, manufacturing operations, and global supply chains.

PayPal faces intense regulatory oversight across global payments, cryptocurrency, artificial intelligence, anti-money laundering, and antitrust. Cybersecurity, fraud mitigation, and heavy reliance on third-party payment networks and bank partners dominate operational risks.

Silicon Laboratories faces heavy cyclicality in the semiconductor market alongside intense competition in mixed-signal products. The company relies entirely on third-party manufacturers, particularly in Asia, for wafer fabrication and assembly. Operations are exposed to cybersecurity threats amplified by remote work and geopolitical conflicts like Russia-Ukraine and the Middle East.

The company relies entirely on in-licensed pre-clinical asset Telomir-1 without owning underlying patents.

Boeing faces heavy concentration on commercial airline demand and defense fixed-price contracts.

FirstCash faces heavy regulatory scrutiny from the CFPB and FTC regarding pawn and consumer lending practices. International operations in Latin America expose the company to currency fluctuations and foreign political risks. Heavy dependence on gold commodity prices and store lease costs directly impact retail profitability.

Focuses on commercial real estate debt investments, heavily relying on transitional loans and leverage through repurchase facilities.

U.S. government defense programs and spending are major drivers, exposing RTX to budget, contract, audit, and compliance risks.

da Vinci and Ion depend on physician, patient, payer, and hospital acceptance against competing treatment options.

Competition from AT&T, Verizon and DISH pressures wireless pricing, margins and customer growth across market segments.